$2.0B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | RVMD Revolution Medicines Inc | 2.6M | +0.0% | $483M | 24.2% |
| 2 | RLAY Relay Therapeutics Inc | 16.0M | +11.2% | $300M | 15.0% |
| 3 | WGS Genedx Holdings Corp | 3.7M | +23.3% | $254M | 12.7% |
| 4 | BIOLIFE SOLUTIONS INC Biolife Solutions Inc | 4.7M | −21.9% | $131M | 6.6% |
| 5 | ILMN Illumina Inc | 530,000 | +0.0% | $93M | 4.7% |
| 6 | LAB Standard Biotools Inc | 88.8M | +0.0% | $73M | 3.7% |
| 7 | GPCR Structure Therapeutics Inc | 1.2M | +0.0% | $63M | 3.2% |
| 8 | DNLI Denali Therapeutics Inc | 2.0M | +11.1% | $53M | 2.6% |
| 9 | NGNE Neurogene Inc | 1.5M | +8.8% | $49M | 2.4% |
| 10 | BEAM Beam Therapeutics Inc | 1.4M | +0.0% | $46M | 2.3% |
| 11 | TXG 10X Genomics Inc | 1.1M | −53.8% | $40M | 2.0% |
| 12 | SRRK Scholar Rock Hldg Corp | 665,000 | +90.0% | $37M | 1.8% |
| 13 | PSNL Personalis Inc | 2.5M | +59.4% | $34M | 1.7% |
| 14 | GRAL Grail Inc | 480,000 | +108.7% | $33M | 1.6% |
| 15 | GH Guardant Health Inc | 185,000 | −41.3% | $28M | 1.4% |
| 16 | MAZE Maze Therapeutics Inc | 843,857 | +11.2% | $25M | 1.3% |
| 17 | HIMS Hims & Hers Health Inc | 700,000 | +0.0% | $24M | 1.2% |
| 18 | ALNY Alnylam Pharmaceuticals Inc | 75,000 | +0.0% | $23M | 1.1% |
| 19 | TSHA Taysha Gene Therapies Inc | 3.2M | +0.0% | $22M | 1.1% |
| 20 | AGMB Agomab Therapeutics Nv | 1.6M | +0.0% | $20M | 1.0% |
| 21 | SEPN Septerna Inc | 553,268 | +0.0% | $19M | 0.9% |
| 22 | PBLS Parabilis Medicines Inc | 645,690 | — | $18M | 0.9% |
| 23 | SION Sionna Therapeutics Inc | 400,000 | — | $18M | 0.9% |
| 24 | VCYT Veracyte Inc | 276,308 | +0.0% | $16M | 0.8% |
| 25 | ANL Adlai Nortye Ltd | 1.2M | +132.1% | $14M | 0.7% |
| 26 | PRME Prime Medicine Inc | 3.2M | +0.0% | $12M | 0.6% |
| 27 | ABSI Absci Corporation | 973,260 | +0.0% | $11M | 0.6% |
| 28 | DGX Quest Diagnostics Inc | 50,000 | +0.0% | $11M | 0.5% |
| 29 | SRPT Sarepta Therapeutics Inc | 470,000 | — | $8M | 0.4% |
| 30 | UNIQURE NV Uniqure Nv | 150,000 | — | $7M | 0.3% |
| 31 | NTLA Intellia Therapeutics Inc | 355,000 | +0.0% | $6M | 0.3% |
| 32 | MRNA Moderna Inc | 75,000 | +0.0% | $5M | 0.3% |
| 33 | IRON Disc Medicine Inc | 65,000 | +0.0% | $5M | 0.2% |
| 34 | GLUE Monte Rosa Therapeutics Inc | 186,014 | +0.0% | $5M | 0.2% |
| 35 | IPSC Century Therapeutics Inc | 1.2M | +0.0% | $3M | 0.2% |
| 36 | CTNM Contineum Therapeutics Inc | 148,333 | +0.0% | $2M | 0.1% |
| 37 | BBOT Bridgebio Oncology Therapeut | 282,312 | +0.0% | $2M | 0.1% |
| 38 | EDIT Editas Medicine Inc | 445,000 | — | $1M | 0.1% |
| 39 | PACIFIC BIOSCIENCES CALIF IN Pacific Biosciences Calif In | 723,767 | +0.0% | $1M | 0.1% |
| 40 | KARD Kardigan Inc | 50,000 | — | $1M | 0.1% |
| 41 | RXRX Recursion Pharmaceuticals In | 165,323 | +0.0% | $606,735 | 0.0% |
| 42 | DNA Ginkgo Bioworks Holdings Inc | 36,493 | +0.0% | $361,646 | 0.0% |
| 43 | TNYA Tenaya Therapeutics Inc | 361,969 | +0.0% | $267,531 | 0.0% |